Digital Assessment of Speech and Fine Motor Control in ALS
Part of paid clinical trials in Hershey, Pennsylvania.
- Sponsor
- Milton S. Hershey Medical Center
- Study ID
- NCT06315673
- Status
- Recruiting
Conditions
- Amyotrophic Lateral Sclerosis
- Primary Lateral Sclerosis
- Progressive Muscular Atrophy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Digital Speech and Handwriting Assessment — BEHAVIORALSubjects may complete all or some of these tests, depending on functional ability. * Handwriting battery * Pattern tracing battery * Speech Assessment Battery
Study Details
This is a single-session, case-control study that incorporates digital tools for assessing speech and motor function in motor neuron disease. Patients with motor neuron disease (including amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), and progressive muscular atrophy (PMA)) and age-matched healthy controls will be enrolled. Subjects will complete a speech and handwriting assessment during the study visit on a tablet computer (BioSensics LLC, Newton, MA). We will explore whether these digital biomarkers are sensitive to functional disease severity as reported by the ALS Functional Rating Scale - Revised (ALFRS-R) \[1\]. We will also compare assessment data between the patient and control groups.
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Jul 2025
- Primary completion
- Mar 30, 2026
- Completion
- Mar 30, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: PatientIndividuals with diagnosis of definite, probable, probable laboratory-supported, or possible ALS by revised El Escorial research criteria \[2\], primary lateral sclerosis (PLS), or progressive muscular atrophy (PMA).
- Arm: ControlIndividuals with no neurological or orthopedic problems that affects their speech or handwriting AND age-matched to the existing patient cohort.
Primary Outcome Measure
Speaking rate during a standardized passage [ Time Frame: baseline ]
Central Contacts
- Andrew Geronimo, PhD7175310003
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 |
Find similar trials in Hershey, PA
Related Studies
- Phenotype, Genotype & Biomarkers in ALS and Related DisordersEnrolling By Invitation · University of Miami · Palo Alto, California
- HEALEY ALS Platform Trial - Master ProtocolPHASE2/PHASE3 · Recruiting · Merit E. Cudkowicz, MD · Phoenix, Arizona
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)Recruiting · Mayo Clinic · Birmingham, Alabama
- Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical ImplicationsRecruiting · Penn State University · University Park, Pennsylvania